An estimated 12.3% of Americans over the age of 21 have masked hypertension.
Researchers observed a connection between advancing age, systemic inflammation, cardiovascular disease, and caffeine.
The ACP and the AAFP has released a joint recommendation for the pharmacologic treatment of hypertension in adults aged 60 years and older.
Individuals who perform their physical activity in 1 or 2 sessions during the week can still reduce their risk of mortality.
Prescription rates for statins were dependent on age among patients with severe dyslipidemia.
Researchers examined the association between statin use and the risk of uterine fibroids and fibroid-related symptoms.
The use of a decision aid in patients at risk of acute coronary syndrome increased patient knowledge about their risk.
Depending on race, sex, and ethnicity, the right statin type may lower the risk of Alzheimer disease.
Drinking small amounts of alcohol may increase the risk of atrial fibrillation.
The prevalence of elevated blood pressure rates shifted from high-income to low- and middle-income countries.
Patients who also took either lovastatin or simvastatin had a 40% higher risk of major hemorrhage than those who took other statins.
The reduction in thromboembolism was attenuated after accounting for competing death events.
The task force finalizes recommendations for statin therapy among adults between 40 and 75 years of age.
Caffeine consumption in patients with systolic heart failure does not induce arrhythmias both at rest and during physical exercise.
One in 6 patients hospitalized for a first episode of syncope experiences a pulmonary embolism.
Depression can occur in approximately 1 in 5 patients who have chronic stable angina.
The AABB evaluated studies that examined hemoglobin thresholds for red blood cell transfusion and red blood cell storage duration.
Some individual NSAIDs may be linked to increased risk of hospital admission for heart failure.
Resumption of antithrombotic therapy after gastrointestinal bleeding in patients with atrial fibrillationOctober 06, 2016
Resuming antithrombotic therapy with in patients with atrial fibrillation and a serious gastrointestinal bleed results in better overall mortality outcomes.
Statin-based therapy had a smaller effect in reducing major vascular events in patients with advanced chronic kidney disease.
Researchers found that dietary changes, other medications, and surgery can also lower cardiovascular risk.
Researchers observed a lower frequency of statin recommendation with ESC guidelines compared with the AHA/ACC guidelines.
Patients with obstructive sleep apnea did not have reduced cardiovascular events after CPAP in addition to usual care.
A target intake of at least 500 mg/d is recommended to combat sight-threatening diabetic retinopathy.
The American Heart Association has released a science advisory regarding the cardiovascular risks associated with sedentary behavior.
Current evidence is insufficient to weigh the balance of benefits and harms of screening.
Patients with type 2 diabetes with systolic blood pressure lower than 140 mm Hg have a lower risk of cardiovascular events.
At 16 months, 30.3% of patients either died or experienced worsening heart failure.
Reductions in disease risk were observed for an intake as high as 7.5 servings of whole grains per day.
Non-vitamin K antagonist oral anticoagulants perform similarly to warfarin for patients with atrial fibrillation.